Q-omics provides the consensus-scored GUSBP13 profile across patient tissues and cancer cell-line models. GUSBP13 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in THCA. Among the 18 cancer types available for tumor–normal comparison, GUSBP13 is differentially expressed in 7, with the highest sampling consensus in THCA. Additionally, GUSBP13 RNA expression shows 16,974 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight THCA, and THYM as cancer lineages where GUSBP13 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for GUSBP13 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes GUSBP13 survival associations across molecular data types. GUSBP13 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible GUSBP13 RNA expression–survival associations across cancer types. High GUSBP13 expression shows unfavorable associations in THCA, LGG and UCEC, but favorable associations in UVM, READ and DLBC. The THCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .003). Together, the overview and detailed table identify THCA as the clearest survival context for GUSBP13 RNA expression.
This table summarizes GUSBP13 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for GUSBP13. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. GUSBP13 shows lower tumor expression in THCA and KICH and higher tumor expression in STAD, LIHC, CHOL and BRCA. The THCA box plot shows higher GUSBP13 RNA expression in normal versus tumor tissue (log2 FC = −0.429, t-test p < 0.001).
This table shows molecular features associated with GUSBP13 in patient tissues and cancer cell lines. In patient samples, GUSBP13 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
